Novel Medicines and Strategies in Cancer Treatment and Prevention

Cancer is one of the leading causes of death around the world [1]. There are a number of challenges that the limitation of new drugs to potentiate antitumor therapies [2]. Furthermore, despite a positive response to initial treatment, many patients eventually develop a local recurrence and spread of the primary tumor [3–5]. Additional prognostic biomarkers are urgently needed to improve decision making regarding adjuvant therapy for these patients.